Acadian Asset Management
FLGT icon

Acadian Asset Management’s Fulgent Genetics FLGT Stock Holding History

Acadian Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Sell
1,017,913
-216,038
-18% -$3.66M 0.02% 411
2026
Q1 		$19.6M Buy
1,233,951
+48,061
+4% +$1.04M 0.03% 383
2025
Q4 		$31.1M Buy
1,185,890
+45,727
+4% +$1.19M 0.05% 269
2025
Q3 		$25.8M Buy
1,140,163
+22,246
+2% +$458K 0.04% 283
2025
Q2 		$22.2M Buy
1,117,917
+311,976
+39% +$6.08M 0.05% 295
2025
Q1 		$13.6M Buy
805,941
+446,076
+124% +$7.6M 0.04% 276
2024
Q4 		$6.64M Buy
359,865
+59,287
+20% +$1.16M 0.02% 444
2024
Q3 		$6.53M Buy
300,578
+237,854
+379% +$5.32M 0.02% 427
2024
Q2 		$1.23M Buy
62,724
+53,680
+594% +$1.12M ﹤0.01% 927
2024
Q1 		$195K Buy
+9,044
New +$225K ﹤0.01% 1187
2023
Q2 		– Sell
-9,799
Closed -$305K – 1788
2023
Q1 		$305K Hold
9,799
– – ﹤0.01% 1166
2022
Q4 		$291K Sell
9,799
-11,036
-53% -$395K ﹤0.01% 1191
2022
Q3 		$793K Buy
20,835
+8,475
+69% +$425K ﹤0.01% 859
2022
Q2 		$675K Sell
12,360
-2,963
-19% -$163K ﹤0.01% 900
2022
Q1 		$955K Hold
15,323
– – ﹤0.01% 838
2021
Q4 		$1.54M Sell
15,323
-3,108
-17% -$273K 0.01% 724
2021
Q3 		$1.66M Sell
18,431
-20,755
-53% -$1.89M 0.01% 725
2021
Q2 		$3.61M Buy
+39,186
New +$3.13M 0.01% 552
2020
Q3 		– Sell
-147,717
Closed -$2.36M – 2233
2020
Q2 		$2.36M Sell
147,717
-70,389
-32% -$1.08M 0.01% 690
2020
Q1 		$2.35M Buy
218,106
+87,218
+67% +$1.21M 0.01% 560
2019
Q4 		$1.69M Buy
130,888
+110,207
+533% +$1.31M 0.01% 739
2019
Q3 		$214K Buy
+20,681
New +$196K ﹤0.01% 1306

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Acadian Asset Management's FLGT Position: Q2 2026 in Review

Acadian Asset Management reduced its Fulgent Genetics (FLGT) stake by 18% in Q2 2026, selling an estimated $3.66M and leaving 1,017,913 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #411.

Acadian Asset Management first reported a position in FLGT in Q3 2019 and has held it in 22 quarters since. The position peaked at $31.1M in Q4 2025. 92 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Acadian Asset Management held 1,017,913 shares of Fulgent Genetics worth $20.9M as of Q2 2026.
  • Acadian Asset Management sold 216,038 Fulgent Genetics shares in Q2 2026, an estimated $3.66M.
  • Fulgent Genetics made up 0.02% of Acadian Asset Management's portfolio in Q2 2026, its #411 holding.
  • Acadian Asset Management first reported a position in Fulgent Genetics in Q3 2019 and has held it in 22 quarters since.
  • Acadian Asset Management's Fulgent Genetics position peaked at $31.1M in Q4 2025.
  • 92 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.